QA: GRI Bio Inc in us_pharma/2023

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001824293_2024_GRI_Bio_Inc.pdf

Logs

warning Missing logo subcommand.report {}

Graph

Absolute values for 0001824293, GRI Bio Inc

  xvar xval
0 AssetsCurrent 2,934,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 8,000
3 remainder_Assets 14,000
4 LiabilitiesCurrent 2,697,000
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 8,155,000
9 ResearchAndDevelopmentExpense 3,232,000
10 remainder_Expenses 0
11 remainder_Revenues 0
12 remainder_NetIncome -1,650,000
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 2,956,000
1 Liabilities 2,697,000
2 Expenses 11,387,000
3 Revenues 0
4 StockholdersEquity 259,000
5 NetIncome -13,037,000
6 ComprehensiveNetIncome -13,037,000
7 BaseVar 9,345,000
8 EconomicCapitalRatiobeforeLimitedLiability -4.41
9 EconomicCapitalRatio 0.297

Edgar->Model Mapping

Feature Distribution

Change over Time